🤝 Partner Spotlight: SmartImmune

This week, we’re excited to highlight our partnership with @Smart Immune, a French clinical-stage biotech company developing ProTcell, a T-cell progenitor therapy platform that harnesses the patient's own thymus to rapidly re-arm the immune system against cancer and infection.

Here’s what Pierre Heimendinger, CTO, had to say about working with INITS:

« Through Smart Immune's CMC and clinical projects and the development of our SMART101 product, I have greatly appreciated INITS' support. It has provided us with a human quality in our professional relations, but above all with cutting-edge technical expertise and sound advice, enriched by an entrepreneurial vision. The responsiveness of Christelle, Isabelle, Laura, and Margot in leading the pharmaceutical development of our MTIs was essential to our success and our clinical ambitions. Many thanks for your ability to adapt and your invaluable ongoing support for SmartImmune. »

At INITS, we’re proud to play a role in helping innovative therapies like SMART101 reach the clinic. Our mission is to deliver tailored, high-quality support at every stage, ensuring our partners can meet their clinical and regulatory goals.

Thank you, Smart Immune, for your trust and collaboration. We look forward to continuing this exciting journey together!

#Partnership #GeneTherapy #CellTherapy #CMC #ATMPs #Biomanufacturing #Innovation